Double Medical (China) Performance
| 002901 Stock | 35.12 0.39 1.10% |
Double Medical has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.69, which means possible diversification benefits within a given portfolio. As returns on the market increase, Double Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Double Medical is expected to be smaller as well. Double Medical Technology right now shows a risk of 2.16%. Please confirm Double Medical Technology standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to decide if Double Medical Technology will be following its price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Double Medical Technology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Double Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Forward Dividend Yield 0.0071 | Payout Ratio 0.7425 | Forward Dividend Rate 0.25 | Ex Dividend Date 2024-06-24 |
1 | SYK 3 Medical Devices Stocks Poised for Solid Growth - StockNews.com | 11/07/2024 |
2 | Tactile Systems Technology Stock Acquired Sen. Tina Smith - MarketBeat | 11/22/2024 |
3 | Double Medical Technology Inc. Not Lagging Industry On Growth Or Pricing - Simply Wall St | 01/07/2025 |
| Begin Period Cash Flow | 214.1 M |
Double |
Double Medical Relative Risk vs. Return Landscape
If you would invest 3,470 in Double Medical Technology on November 5, 2024 and sell it today you would earn a total of 42.00 from holding Double Medical Technology or generate 1.21% return on investment over 90 days. Double Medical Technology is generating 0.0424% of daily returns and assumes 2.1611% volatility on return distribution over the 90 days horizon. Simply put, 19% of stocks are less volatile than Double, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Double Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Double Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Double Medical Technology, and traders can use it to determine the average amount a Double Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0196
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 002901 |
Estimated Market Risk
| 2.16 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Double Medical is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Double Medical by adding it to a well-diversified portfolio.
Double Medical Fundamentals Growth
Double Stock prices reflect investors' perceptions of the future prospects and financial health of Double Medical, and Double Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Double Stock performance.
| Return On Equity | 0.0717 | ||||
| Return On Asset | 0.0243 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 13.65 B | ||||
| Shares Outstanding | 414.02 M | ||||
| Price To Book | 4.60 X | ||||
| Price To Sales | 7.51 X | ||||
| Revenue | 1.53 B | ||||
| Gross Profit | 1.28 B | ||||
| EBITDA | 282.18 M | ||||
| Net Income | 58.97 M | ||||
| Total Debt | 316.13 M | ||||
| Book Value Per Share | 7.75 X | ||||
| Cash Flow From Operations | 73.86 M | ||||
| Earnings Per Share | 0.48 X | ||||
| Total Asset | 4.64 B | ||||
| Retained Earnings | 1.28 B | ||||
About Double Medical Performance
By analyzing Double Medical's fundamental ratios, stakeholders can gain valuable insights into Double Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Double Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Double Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Double Medical is entity of China. It is traded as Stock on SHE exchange.Things to note about Double Medical Technology performance evaluation
Checking the ongoing alerts about Double Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Double Medical Technology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 86.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Double Medical Technology Inc. Not Lagging Industry On Growth Or Pricing - Simply Wall St |
- Analyzing Double Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Double Medical's stock is overvalued or undervalued compared to its peers.
- Examining Double Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Double Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Double Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Double Medical's stock. These opinions can provide insight into Double Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Double Stock analysis
When running Double Medical's price analysis, check to measure Double Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Double Medical is operating at the current time. Most of Double Medical's value examination focuses on studying past and present price action to predict the probability of Double Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Double Medical's price. Additionally, you may evaluate how the addition of Double Medical to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |